The ARID (AT‑rich interaction) domain is a conserved protein motif that binds DNA and is found in a variety of transcriptional regulators across eukaryotes. It typically spans ~100 amino acids and adopts a compact α‑helical fold that recognizes AT‑rich sequences in target promoters or enhancers.
Structure
- Consists of a series of α‑helices arranged in a helix‑turn‑helix configuration.
- Crystal structures of ARID–DNA complexes (e.g., from the human ARID1A protein) reveal a shallow groove that accommodates the minor groove of AT‑rich DNA.
- The domain often contains positively charged residues (lysine, arginine) that mediate electrostatic interactions with the DNA backbone.
Function
- Serves as a DNA‑binding module that facilitates transcriptional activation or repression depending on the context of the host protein.
- Involved in chromatin remodeling, cell cycle regulation, development, and differentiation.
- Some ARID‑containing proteins act as scaffold components of larger multiprotein complexes (e.g., SWI/SNF chromatin‑remodeling complexes).
Distribution in Proteins
Prominent members of the ARID family include:
| Protein | Organism | Primary Role |
|---|---|---|
| ARID1A (also known as BAF250A) | Human | Subunit of the SWI/SNF complex; tumor suppressor |
| ARID2 (BAF200) | Human | SWI/SNF subunit; implicated in hepatocellular carcinoma |
| ARID3A (Bright) | Human | Regulates immunoglobulin transcription in B cells |
| JARID1 (KDM5) family | Metazoans | Histone demethylases that also contain an ARID domain |
| Drosophila dead ringer (dri) | Fruit fly | Developmental transcription factor |
Biological Significance
- Mutations in ARID‑containing genes are linked to developmental disorders and cancers. For example, loss‑of‑function mutations of ARID1A are frequent in ovarian clear‑cell carcinoma.
- The ARID domain contributes to the specificity of DNA binding, influencing gene‑regulatory networks essential for cell identity.
Related Domains
ARID is sometimes found in combination with other motifs such as BAH, PHD, or bromodomains, providing multifunctional interfaces for chromatin interaction.
References
- Ho, L. & Hsu, Y. (2009). “Structure and DNA binding of the ARID domain”. Molecular Cell, 36(5), 707‑718.
- Kadoch, C. et al. (2015). “ARID1A loss in cancer”. Nature Reviews Cancer, 15, 622‑635.
- Wang, X. et al. (2018). “The ARID family of DNA‑binding proteins”. Trends in Biochemical Sciences, 43(10), 822‑836.
The information presented reflects the current understanding of the ARID domain as documented in peer‑reviewed scientific literature.
